In a research note released Friday, Argus analyst John Eade upgraded his rating on Paychex (NASDAQ:PAYX) to a Buy rating from a Hold with a …
In a research report published this morning, Argus analyst John Eade maintained a Hold rating on ADT Corp. (NYSE:ADT) with a $33 fair …
In a research note published today, Argus analyst John Eade upgraded GlaxoSmithKline (NYSE:GSK) to a Buy rating with a $55 price target, on …
In a research note released today, Argus analyst John Eade maintained a Buy rating on shares of AECOM Technology Corporation (ACM), with a fair value of $38 per share. “We …
